Biological magnetic cellular spheroids as building blocks for tissue engineering
Source abstract
Abstract
Magnetic nanoparticles (MNPs), primarily iron oxide nanoparticles, have been incorporated into cellular spheroids to allow for magnetic manipulation into desired shapes, patterns and 3-D tissue constructs using magnetic forces. However, the direct and long-term interaction of iron oxide nanoparticles with cells and biological systems can induce adverse effects on cell viability, phenotype and function, and remain a critical concern. Here we report the preparation of biological magnetic cellular spheroids containing magnetoferritin, a biological MNP, capable of serving as a biological alternative to iron oxide magnetic cellular spheroids as tissue engineered building blocks. Magnetoferritin NPs were incorporated into 3-D cellular spheroids with no adverse effects on cell viability up to 1 week. Additionally, cellular spheroids containing magnetoferritin NPs were magnetically patterned and fused into a tissue ring to demonstrate its potential for tissue engineering applications. These results present a biological approach that can serve as an alternative to the commonly used iron oxide magnetic cellular spheroids, which often require complex surface modifications of iron oxide NPs to reduce the adverse effects on cells.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Iron Metabolism and Disorders · Electrohydrodynamics and Fluid Dynamics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (34)
Show source-provided references
1. Carbon-nanotube-embedded hydrogel sheets for engineering cardiac constructs and bioactuators10.1021/nn305559j ↗
2. Dynamically crosslinked gold nanoparticle–hyaluronan hydrogels10.1002/adma.201001436 ↗
3. Nanotechnological strategies for engineering complex tissues10.1038/nnano.2010.246 ↗
4. Tissue engineering – current challenges and expanding opportunities10.1126/science.1069210 ↗
5. Nanotechnology in vascular tissue engineering: from nanoscaffolding towards rapid vessel biofabrication10.1016/j.tibtech.2008.03.001 ↗
6. Generation and manipulation of magnetic multicellular spheroids10.1016/j.biomaterials.2009.12.047 ↗
7. Cell patterning using magnetite nanoparticles and magnetic force10.1002/bit.21322 ↗
8. Application of magnetic force-based cell patterning for controlling cell–cell interactions in angiogenesis10.1002/bit.22104 ↗
9. Enhanced cell viability via strain stimulus and fluid flow in magnetically actuated scaffolds10.1002/bit.24736 ↗
10. Cell-patterning using poly (ethylene glycol)-modified magnetite nanoparticles10.1002/jbm.a.32313 ↗
11. Magnetic manipulation and spatial patterning of multi-cellular stem cell aggregates10.1039/c1ib00064k ↗
12. The effect of RGD peptide-conjugated magnetite cationic liposomes on cell growth and cell sheet harvesting10.1016/j.biomaterials.2005.03.039 ↗
13. Magnetic forces enable rapid endothelialization of synthetic vascular grafts10.1161/CIRCULATIONAHA.105.001446 ↗
14. The role of cobalt ferrite magnetic nanoparticles in medical science10.1016/j.msec.2012.09.003 ↗
15. Manganese ferrite nanoparticle micellar nanocomposites as MRI contrast agent for liver imaging10.1016/j.biomaterials.2009.02.001 ↗
16. On the suitability of nanocrystalline ferrites as a magnetic carrier for drug delivery: functionalization, conjugation and drug release kinetics10.1016/j.actbio.2006.10.006 ↗
17. Synthesis and magnetic studies of uniform iron nanorods and nanospheres10.1021/ja001628c ↗
18. Investigations on magnetic properties and structure for carbon encapsulated nanoparticles of Fe Co, Ni10.1016/S0921-5093(00)00628-6 ↗
19. Dextran and polymer polyethylene glycol (PEG) coating reduce both 5 and 30nm iron oxide nanoparticle cytotoxicity in 2D and 3D cell culture10.3390/ijms13055554 ↗
20. Labeling transplanted mice islet with polyvinylpyrrolidone coated superparamagnetic iron oxide nanoparticles for in vivo detection by magnetic resonance imaging10.1088/0957-4484/20/36/365101 ↗
21. Antibiofouling polymer-coated superparamagnetic iron oxide nanoparticles as potential magnetic resonance contrast agents for in vivo cancer imaging10.1021/ja061529k ↗
22. Formulation and in vitro characterization of composite biodegradable magnetic nanoparticles for magnetically guided cell delivery10.1007/s11095-012-0675-y ↗
23. Magnetically driven plasmid DNA delivery with biodegradable polymeric nanoparticles10.1096/fj.06-8070com ↗
24. Safety profile of ultrasmall superparamagnetic iron oxide ferumoxtran-10: phase II clinical trial data10.1002/(SICI)1522-2586(199902)9:2<291::AID-JMRI21>3.0.CO;2-# ↗
25. Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy10.1021/ar200084x ↗
26. Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T1 contrast agents for labeling and MRI tracking of adipose-derived mesenchymal stem cells10.1021/ja1084095 ↗
27. Ferritin: structure, gene regulation, and cellular function in animals, plants, and microorganisms10.1146/annurev.bi.56.070187.001445 ↗
28. Serum ferritin concentration and iron stores in normal subjects10.1136/jcp.26.10.770 ↗
29. Iron incorporation into apoferritin. The role of apoferritin as a ferroxidase10.1016/S0021-9258(18)69288-9 ↗
30. Ferroxidase kinetics of human liver apoferritin, recombinant H-chain apoferritin, and site-directed mutants10.1021/bi00087a015 ↗
31. Biomimetic synthesis and characterization of magnetic proteins (magnetoferritin)10.1021/cm970421o ↗
32. How to quantify iron in an aqueous or biological matrix: a technical note10.1002/cmmi.291 ↗
33. Size-dependent properties of magnetoferritin10.1088/0957-4484/21/46/465707 ↗
34. Synthesis and characterization of magnetoferritin10.12693/APhysPolA.121.1318 ↗